Kirsten L. Bryant

Statistics

Publications

Citations

2.6K

H-Index

Active since

2011

Affiliations

University of North Carolina at Chapel Hill(Current)

George Mason University

Cornell University

Translational Genomics Research Institute

University of Helsinki

Kirsten L. Bryant is an author at University of North Carolina at Chapel Hill specializing in oncology, molecular oncology, and oncogenic signaling pathways.

ORCID

Publications per year

2011–2025

Publications

Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer

Kirsten L. Bryant, Clint A. Stalnecker, Daniel Zeitouni et al. · Nature Medicine · 2019 · 715 citations

Life Sciences, Cell Biology, Oncology +16

Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells

Marc A. Antonyak, Bo Li, Lindsey K. Boroughs et al. · Proceedings of the National Academy of Sciences · 2011 · 495 citations · Full text

Medicine, Cell Biology, Oncology +13

Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression

Tikvah K. Hayes, Nicole F. Neel, Chaoxin Hu et al. · Cancer Cell · 2015 · 275 citations · Full text

Medicine, Cancer Biology, Oncology +17

Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer

G. Aaron Hobbs, Nicole M. Baker, Anne M. Miermont et al. · Cancer Discovery · 2019 · 226 citations · Full text

Medicine, Genetics, Oncology +12

KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism

Angelina V. Vaseva, Devon R. Blake, Thomas S.K. Gilbert et al. · Cancer Cell · 2018 · 192 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

1–5 of 20